Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Updates in melanoma and skin cancers

Dr Sanjiv Agarwala - St. Luke’s Cancer Center, Philadelphia, USA

Updates in melanoma and skin cancers ( Dr Sanjiv Agarwala - St. Luke’s Cancer Center, Philadelphia, USA )

Gynaecological cancer: New targets and immunotherapy developments

Dr Mark Shahin - Jefferson Health, Philadelphia, USA

Gynaecological cancer: New targets and immunotherapy developments ( Dr Mark Shahin - Jefferson Health, Philadelphia, USA )

Molecular oncology and translational medicine

Dr Gregg Fields - Florida Atlantic University, Florida, USA

Molecular oncology and translational medicine ( Dr Gregg Fields - Florida Atlantic University, Florida, USA )

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios

Dr Luis Raez - Memorial Healthcare System, Florida, USA

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios ( Dr Luis Raez - Memorial Healthcare System, Florida, USA )

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal...

Dr Ronan Kelly - Baylor University Medical Center, Texas, USA

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis ( Dr Ronan Kelly - Baylor University Medical Center, Texas, USA )

Addressing cancer disparities in Hispanic populations in the US and in LMICs

Dr Luis Raez, Prof Eduardo Cazap, Ms Sybil Green, Dr Don Dizon and Dr Gilberto...

Addressing cancer disparities in Hispanic populations in the US and in LMICs ( Dr Luis Raez, Prof Eduardo Cazap, Ms Sybil Green, Dr Don Dizon and Dr Gilberto Lopes )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

Lenvatinib plus pembrolizumab versus standard of care for previously treated...

Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer ( Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan )

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite...

Dr Andrea Bullock - Beth Israel Deaconess Medical Center, Boston, USA

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer ( Dr Andrea Bullock - Beth Israel Deaconess Medical Center, Boston, USA )

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

Dr Michael White - MD Anderson Cancer Center, Houston, USA

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma ( Dr Michael White - MD Anderson Cancer Center, Houston, USA )

The role of the workforce in implementing Choosing Wisely in cancer care

Dr Nazik Hammad - Cancer Centre of Southeastern Ontario, Kingston, Canada

The role of the workforce in implementing Choosing Wisely in cancer care ( Dr Nazik Hammad - Cancer Centre of Southeastern Ontario, Kingston, Canada )

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

More from ecancer